Advanced search
Publication Cover
Expert Review of Hematology Volume 8, 2015 - Issue 3
Submit an article Journal homepage
1,604
Views
9
CrossRef citations to date
0
Altmetric
Editorial

Multiple myeloma: is a shift toward continuous therapy needed to move forward?

Tommasina GuglielmelliUnit of Hematology, ‘S. Luigi Gonzaga’ Hospital, Orbassano, Italy
&
Antonio PalumboMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, ItalyCorrespondence[email protected]
Pages 253-256 | Published online: 12 Jan 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Piotr Smolewski & Dominika Rydygier. (2019) Ixazomib: an investigational drug for the treatment of lymphoproliferative disorders. Expert Opinion on Investigational Drugs 28:5, pages 421-433.
Read now

Articles from other publishers (8)

Zeki Kocaata, Thomas Wilke, Franz Fischer, Robert Welte & Hermann Einsele. (2022) Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis. PharmacoEconomics - Open 6:4, pages 619-628.
Crossref
Qingqing Wang, Zhigao Dong, Junnan Su, Jinmei Huang, Pingping Xiao, Lihong Tian, Yongquan Chen, Lili Ma & Xuyan Chen. (2021) Ixazomib inhibits myeloma cell proliferation by targeting UBE2K. Biochemical and Biophysical Research Communications 549, pages 1-7.
Crossref
Shaji K. Kumar, Jesus G. Berdeja, Ruben Niesvizky, Sagar Lonial, Jacob P. Laubach, Mehdi Hamadani, A. Keith Stewart, Parameswaran Hari, Vivek Roy, Robert Vescio, Jonathan L. Kaufman, Deborah Berg, Eileen Liao, S. Vincent Rajkumar & Paul G. Richardson. (2019) Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance. Leukemia 33:7, pages 1736-1746.
Crossref
Neeraj Gupta, Michael J. Hanley, Cindy Xia, Richard Labotka, R. Donald Harvey & Karthik Venkatakrishnan. (2018) Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor. Clinical Pharmacokinetics 58:4, pages 431-449.
Crossref
Khalid Ahmed Al-Anazi. 2019. Update on Multiple Myeloma. Update on Multiple Myeloma.
Paul G. Richardson, Jesus F. San Miguel, Philippe Moreau, Roman Hajek, Meletios A. Dimopoulos, Jacob P. Laubach, Antonio Palumbo, Katarina Luptakova, Dorothy Romanus, Tomas Skacel, Shaji K. Kumar & Kenneth C. Anderson. (2018) Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting. Blood Cancer Journal 8:11.
Crossref
Paul G. Richardson, Craig C. Hofmeister, Cara A. Rosenbaum, Myo Htut, David H. Vesole, Jesus G. Berdeja, Michaela Liedtke, Ajai Chari, Stephen D. Smith, Daniel Lebovic, Noopur Raje, Catriona Byrne, Eileen Liao, Neeraj Gupta, Alessandra Di Bacco, Jose Estevam, Deborah Berg & Rachid Baz. (2018) Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma. British Journal of Haematology 182:2, pages 231-244.
Crossref
Pieter Sonneveld, Edwin De Wit & Philippe Moreau. (2017) How have evolutions in strategies for the treatment of relapsed/refractory multiple myeloma translated into improved outcomes for patients?. Critical Reviews in Oncology/Hematology 112, pages 153-170.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.